Why Best & Less, Cettire, Life360, and Paradigm shares are sinking today

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a decent gain. At the time of writing, the benchmark index is up 0.6% to 7,184.3 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are dropping:

Best & Less Group Holdings Ltd (ASX: BST)

The Best & Less share price is down 12.5% to $2.38. This morning the retailer released a trading update and revealed that like for likes (LFL) sales are down 7.4% during the first 20 weeks of FY 2023. The damage is being done predominantly online, with online LFL sales down 32.9% and LFL store sales down a modest 2.3%.

Cettire Ltd (ASX: CTT)

The Cettire share price is down a further 9% to $1.29. Investors have been selling this online luxury products retailer’s shares in recent sessions following news that its CEO was selling down his holding again. Cettire’s CEO, Dean Mintz, sold 41 million shares at a 13% discount of $1.46 per share for a total consideration of approximately $60 million. Cettire’s shares have now dropped 23% since the sale.

Life360 Inc (ASX: 360)

The Life360 share price is down 5% to $6.40. This morning this location technology company announced the completion of a $50 million institutional placement. These funds were raised at a 6.4% discount of $6.30 and will be used to shore up its balance sheet given the uncertain macroeconomic environment. Not even news that Life360 has received takeover interest has been able to keep the Life360 share price from falling today.

Paradigm Biopharmaceuticals Ltd (ASX: PAR)

The Paradigm share price is down 11% to $1.51. Investors have been selling this pharmaceutical company’s shares after it announced the exit of its CEO after less than five months in the role. No reason was given for the exit. Paradigm has acted fast and named its founder and former CEO, Paul Rennie, as its new leader.

The post Why Best & Less, Cettire, Life360, and Paradigm shares are sinking today appeared first on The Motley Fool Australia.

The current market can be tough to stomach…

But the lower stock markets go, the more attractive some shares become.
And when you can pick up world-class stocks at steep discounts, now could be the time that sets up your family’s fortune.
While we can’t predict which stocks will go up, we’ve uncovered four world-class stocks that can be scooped up for a mere fraction of what they were worth only a few short months ago.
And you won’t believe by how much.
Get the details here.

See The 4 Stocks
*Returns as of November 1 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has positions in Life360, Inc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Inc. The Motley Fool Australia has recommended Cettire Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/8IVT6zg

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *